Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pharmacological biomodulation in cancer].

Acta cientifica venezolana - 1 Jan 2001

Arvelo F, Merentes E

Abstract excerpt

The discovery of the P-glycoprotein as a mediator of multidrug resistance (MDR) represents one of the most important research accomplishments in antineoplastic pharmacology during the last decade. Demonstration of Pgp in epithelial tissues, untreated and chemotherapeutically pretreated human malignancies, and identification of various agents capable of reversing in vitro resistance has generated enthusiasm for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium Channel Blockers
Share to Drug Resistance, Multiple
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Immunologic Factors

Share to Neoplasms

Share to Phenotype

Source

Identifiers

PMID: 11510431

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pharmacological biomodulation in cancer].PMID 11510431Read ↗

[Problems in oncologic pharmacology].Semantic proximity Read ↗

Clinical trials of agents that reverse multidrug resistance. A literature review.Semantic proximity Read ↗

Analysis of the tangled relationships between P‐glycoprotein‐mediated multidrug resistance and the lipid phase of the cell membraneSemantic proximity Read ↗

Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)Semantic proximity Read ↗

Multidrug resistance in oncology: diagnostic and therapeutic approachesSemantic proximity Read ↗

Clinical significance of P-glycoprotein in multidrug resistance malignancies [editorial] [see comments]Semantic proximity Read ↗

Clinical significance of P-glycoprotein in multidrug resistance malignancies [editorial] [see comments]Semantic proximity Read ↗

New Insight into P-Glycoprotein as a Drug TargetSemantic proximity Read ↗

New Insight into P-Glycoprotein as a Drug TargetSemantic proximity Read ↗

The Human Multidrug Resistance-Associated Protein (MRP) Gene Family: From Biological Function to Drug Molecular DesignSemantic proximity Read ↗

Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors.Semantic proximity Read ↗

[P glycoprotein and multidrug resistance].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.